3-Hydroxyphencyclidine (3-HPC), a breakdown product of phencyclidine (PCP), is ever more attracting clinical focus due to limited data suggesting different physiological actions. Present studies indicate that 3-HPC may possess independent impacts on the central system, arguably playing a role to some of the unanticipated reactions related with PCP